Cardiac Tamponade Secondary to Methicillin-Resistant Staphylococcus Aureus Pericarditis

As pericardites bacterianas, apesar da sua baixa incidência e das terapêuticas actuais, apresentam um prognóstico desfavorável, sobretudo quando causadas por Staphylococcus aureus meticilino resistente (MRSA). O Tamponamento cardíaco é uma complicação potencialmente letal nos doentes com pericardites por este agente. Numa Unidade de Cuidados Intensivos, para além da imunossupressão, constituem factores predisponentes para este tipo de infecção, a elevada taxa de colonização nasal e cutânea, assim como a utilização de técnicas invasivas (1) entre as quais a simples colocação de catéteres intravenosos. Relatam-se dois casos clínicos de tamponamento cardíaco em doentes jovens, no contexto de imunossupressão de diferentes etiologias (infecção HIV e pós transplante hepático). Os internamentos foram complicados de quadros sépticos importantes com isolamento de MRSA nos líquidos biológicos e desenvolvimento de pericardite bacteriana e subsequente tamponamento cardíaco. Os autores salientam a importância dos quadros clínicos infecciosos em doentes imunodeprimidos, que constituem uma população cada vez mais numerosa, e a importância da monitorização ecocardiográfica na evolução prognóstica das pericardites bacterianas no contexto de sépsis

Impact of Appropriate Antimicrobial Therapy for Patients with Severe Sepsis and Septic Shock – A Quality Improvement Study

Background There is ample literature available on the association between both time to antibiotics and appropriateness of antibiotics and clinical outcomes from sepsis. In fact, the current state of debate surrounds the balance to be struck between prompt empirical therapy and care in the choice of appropriate antibiotics (both in terms of the susceptibility of infecting organism and minimizing resistance arising from use of broad-spectrum agents). The objective of this study is to determine sepsis bundle compliance and the appropriateness of antimicrobial therapy in patients with severe sepsis and septic shock and its impact on outcomes. Material This study was conducted in the ICU of a tertiary care, private hospital in São Paulo, Brazil. A retrospective cohort study was conducted from July 2005 to December 2012 in patients with severe sepsis and septic shock. Results A total of 1,279 patients were identified with severe sepsis and septic shock, of which 358 (32.1%) had bloodstream infection (BSI). The inpatient mortality rate was 29%. In evaluation of the sepsis bundle, over time there was a progressive increase in serum arterial lactate collection, obtaining blood cultures prior to antibiotic administration, administration of broad-spectrum antibiotics within 1 hour, and administration of appropriate antimicrobials, with statistically significant differences in the later years of the study. We also observed a significant decrease in mortality. In patients with bloodstream infection, after adjustment for other covariates the administration of appropriate antimicrobial therapy was associated with a decrease in mortality in patients with severe sepsis and septic shock (p = 0.023). Conclusions The administration of appropriate antimicrobial therapy was independently associated with a decline in mortality in patients with severe sepsis and septic shock due to bloodstream infection. As protocol adherence increased over time, the crude mortality rate decreased, which reinforces the need to implement institutional guidelines and monitor appropriate antimicrobial therapy compliance

A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting

Background Ventilator-associated pneumonia (VAP) is a common infection in the intensive care unit (ICU) and associated with a high mortality. Methods A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to optimize VAP prevention were performed from October 2008 to December 2010. All of these processes, including the Institute for Healthcare Improvement’s (IHI) ventilator bundle plus oral decontamination with chlorhexidine and continuous aspiration of subglottic secretions (CASS), were adopted for patients undergoing mechanical ventilation. Results We evaluated a total of 21,984 patient-days, and a total of 6,052 ventilator-days (ventilator utilization rate of 0.27). We found VAP rates of 1.3 and 2.0 per 1,000 ventilator days respectively in 2009 and 2010, achieving zero incidence of VAP several times during 12 months, whenever VAP bundle compliance was over 90%. Conclusion These results suggest that it is possible to reduce VAP rates to near zero and sustain these rates, but it requires a complex process involving multiple performance measures and interventions that must be permanently monitored

A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting

Abstract Background Ventilator-associated pneumonia (VAP) is a common infection in the intensive care unit (ICU) and associated with a high mortality. Methods A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to optimize VAP prevention were performed from October 2008 to December 2010. All of these processes, including the Institute for Healthcare Improvement’s (IHI) ventilator bundle plus oral decontamination with chlorhexidine and continuous aspiration of subglottic secretions (CASS), were adopted for patients undergoing mechanical ventilation. Results We evaluated a total of 21,984 patient-days, and a total of 6,052 ventilator-days (ventilator utilization rate of 0.27). We found VAP rates of 1.3 and 2.0 per 1,000 ventilator days respectively in 2009 and 2010, achieving zero incidence of VAP several times during 12 months, whenever VAP bundle compliance was over 90%. Conclusion These results suggest that it is possible to reduce VAP rates to near zero and sustain these rates, but it requires a complex process involving multiple performance measures and interventions that must be permanently monitored.</p

Performance of bundle compliance.

<p>CVP – Central venous pressure.</p><p>ScvO² - Central venous oxygen saturation.</p><p>IPP – Inspiratory Plateau Pressure.</p

Risk factors associated with inadequate antimicrobial therapy in patients with severe sepsis or septic shock patients who had documented bloodstream infection.

<p>OR  =  Odds Ratio; CI  =  Confidance Interval; APACHE  =  Acute Physiology and Chronic Health Evaluation II.</p><p><b>ESKAPE  = </b><b><i>Enterococcus, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter spp.</i></b></p><p>Risk factors associated with inadequate antimicrobial therapy in patients with severe sepsis or septic shock patients who had documented bloodstream infection.</p

Risk factors associated with death for patients with severe sepsis or septic shock and documented bloodstream infection.

<p>OR  =  Odds Ratio; CI  =  Confidence Interval; APACHE  =  Acute Physiology and Chronic Health Evaluation II.</p><p>Risk factors associated with death for patients with severe sepsis or septic shock and documented bloodstream infection.</p

Demographic and clinical characteristics of severe sepsis and septic shock patients.

<p>SD - Standard Deviation.</p

Risk factors associated with death in all patients with severe sepsis or septic shock.

<p>OR  =  Odds Ratio; CI  =  Confidence Interval; APACHE: Acute Physiology and Chronic Health Evaluation II.</p><p>Risk factors associated with death in all patients with severe sepsis or septic shock.</p